United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso
June 15, 2015 at 09:01 AM EDT
nited Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson ...